Parkman Healthcare Partners LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Parkman Healthcare Partners LLC disclosed 89 US equity positions worth $964.6m in its Q1 2026 13F filing. The largest position was SYK at 5.3% of the reported book, followed by DXCM and 4XC1.
What did Parkman Healthcare Partners LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | SYK STRYKER CORPORATION | Healthcare | 5.3% | $50.9m | 154,771 | – | |
| 2 | DXCM DEXCOM INC | Healthcare | 4.5% | $43.3m | 689,822 | – | |
| 3 | 4XC1 KALVISTA PHARMACEUTICALS INC | 3.8% | $36.9m | 1,835,506 | – | ||
| 4 | PODD INSULET CORP | Healthcare | 3.4% | $32.9m | 156,561 | – | |
| 5 | LLY ELI LILLY & CO | Healthcare | 3.3% | $31.8m | 34,616 | – | |
| 6 | PTCT PTC THERAPEUTICS INC | Healthcare | 3.0% | $29.4m | 431,364 | – | |
| 7 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.0% | $28.9m | 497,035 | – | |
| 8 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 2.9% | $28.2m | 448,768 | – | |
| 9 | CVS CVS HEALTH CORP | Healthcare | 2.9% | $27.8m | 387,306 | – | |
| 10 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.7% | $26.1m | 1,207,274 | – | |
| 11 | LIVN LIVANOVA PLC | Healthcare | 2.7% | $25.7m | 403,965 | – | |
| 12 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 2.5% | $24.4m | 269,557 | – | |
| 13 | MBX MBX BIOSCIENCES INC | Healthcare | 2.5% | $23.9m | 800,037 | – | |
| 14 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.2% | $21.6m | 280,575 | – | |
| 15 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.2% | $21.1m | 901,511 | – | |
| 16 | QGEN QIAGEN NV | Healthcare | 2.1% | $20.0m | 500,000 | – | |
| 17 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 1.9% | $18.1m | 711,693 | – | |
| 18 | EYPT EYEPOINT INC | Healthcare | 1.8% | $17.5m | 1,354,800 | – | |
| 19 | ABBV ABBVIE INC | Healthcare | 1.7% | $16.3m | 75,000 | – | |
| 20 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.7% | $16.3m | 1,708,099 | – | |
| 21 | IQV IQVIA HLDGS INC | Healthcare | 1.5% | $14.8m | 86,702 | – | |
| 22 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.4% | $13.7m | 403,525 | – | |
| 23 | ILMN ILLUMINA INC | Healthcare | 1.4% | $13.6m | 110,370 | – | |
| 24 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.4% | $13.4m | 167,155 | – | |
| 25 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.4% | $13.1m | 99,069 | – | |
| 26 | KINIKSA PHARMACEUTICALS INTL | 1.3% | $12.5m | 259,184 | – | ||
| 27 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 1.2% | $11.4m | 411,227 | – | |
| 28 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.2% | $11.2m | 232,093 | – | |
| 29 | MCK MCKESSON CORP | Healthcare | 1.1% | $11.0m | 12,676 | – | |
| 30 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.1% | $11.0m | 336,519 | – | |
| 31 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.1% | $10.9m | 557,936 | – | |
| 32 | WAY WAYSTAR HLDG CORP | Healthcare | 1.1% | $10.7m | 443,058 | – | |
| 33 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.1% | $10.3m | 380,137 | – | |
| 34 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 1.1% | $10.2m | 322,828 | – | |
| 35 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 1.0% | $10.0m | 1,721,264 | – | |
| 36 | THC TENET HEALTHCARE CORP | Healthcare | 1.0% | $9.5m | 50,123 | – | |
| 37 | AORT ARTIVION INC | Healthcare | 1.0% | $9.2m | 252,014 | – | |
| 38 | NUVALENT INC | 0.9% | $9.0m | 88,078 | – | ||
| 39 | ATEC ALPHATEC HLDGS INC | Healthcare | 0.9% | $9.0m | 823,763 | – | |
| 40 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.9% | $8.9m | 26,916 | – | |
| 41 | AXGN AXOGEN INC | Healthcare | 0.9% | $8.9m | 268,160 | – | |
| 42 | IMNM IMMUNOME INC | Healthcare | 0.9% | $8.8m | 403,487 | – | |
| 43 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.9% | $8.6m | 621,458 | – | |
| 44 | IDXX IDEXX LABS INC | Healthcare | 0.9% | $8.4m | 15,000 | – | |
| 45 | WAT WATERS CORP | Healthcare | 0.8% | $7.9m | 26,447 | – | |
| 46 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 0.8% | $7.7m | 551,815 | – | |
| 47 | UPB UPSTREAM BIO INC | 0.7% | $7.1m | 786,783 | – | ||
| 48 | ERAS ERASCA INC | Healthcare | 0.7% | $6.6m | 406,702 | – | |
| 49 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.7% | $6.5m | 77,686 | – | |
| 50 | COO COOPER COS INC | Healthcare | 0.7% | $6.4m | 89,883 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.